Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-027008
Filing Date
2020-10-02
Accepted
2020-10-02 21:00:18
Documents
1
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3385
  Complete submission text file 0000899243-20-027008.txt   4874
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST MONROE ST., SUITE 1575 CHICAGO IL 60606
Business Address
Matthews Judith M. (Reporting) CIK: 0001734033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 201222098